Tamim M. Nazif, MD
Overview
Tamim Nazif, MD is the Director of Clinical Services for the Structural Heart & Valve Center, Director of Clinical Research for the Center for Interventional Vascular Therapy and an assistant professor in medicine at CUMC.
Dr. Nazif specializes in interventional cardiology and the treatment of heart valve disease.
Dr. Nazif attended Columbia University College of Physicians and Surgeons, did his residency at University of California, San Francisco Department of Medicine, San Francisco, CA, and his fellowship in interventional cardiology and Structural Heart Disease at Columbia University Medical Center.
Areas of Expertise / Conditions Treated
- Aortic Disease
- Aortic Stenosis
- Cardiac Catheterization
- Cardiac Valve Replacement
- Cardiology
- Cardiopulmonary Resuscitation
- Cardiovascular Disease
- Cardiovascular Diseases
- Catheterization
- Clinical Research Trials
- Coronary Artery and Valvular Disease
- Heart Disease
- Heart Disease and Women
- Heart Valve Disease
- Heart Valve Repair
- Heart Valve Replacement
- Minimally Invasive Valve Repair
- Mitral/Aortic Valve Replacement
- Mitral Valve Repair
- Mitral Valve Replacement/Repair
- Revascularization
- Stents
- TAVR (Transcatheter Aortic Valve Replacement)
- Valve Reconstruction/Repair
- Valve Replacement
- Valvular Heart Disease
Academic Appointments
- Assistant Professor of Medicine at CUMC
Administrative Titles
- Director of Clinical Research for the Center for Interventional Vascular Therapy
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Lawrence Hospital
Gender
- Male
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs Plan
Amida Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
Credentials & Experience
Education & Training
- Columbia University College of Physicians and Surgeons
- Residency: University of California-San Francisco Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Internal Medicine
- Interventional Cardiology
- Cardiovascular Disease
Research
Grants
UNDERSTANDING PREFERENCES AMONG TRICUSPID VALVE REGURGITATION PATIENTS (P&S Industry Clinical Trial)
Apr 21 2020 - Apr 21 2025
OPTIMIZE PRO TAVR POST MARKET STUDY (P&S Industry Clinical Trial)
Feb 21 2020 - Feb 21 2025
CROSS- SEAL IDE TRIAL: PROSPECTIVE MULTI-CENTER SINGLE ARM STUDY OF CROSS-SEAL SUTURE MEDICATED VASCULAR CLOSURE DEIVE SYSTEM (P&S Industry Clinical Trial)
Nov 6 2019 - Nov 6 2024
EARLY FEASIBILITY STUDY OF THE CARDIOVALVE TRANSFEMORAL MITRAL VALVE SYSTEM (AHEAD) (P&S Industry Clinical Trial)
May 6 2019 - May 6 2024
ONYX ONE CLEAR STUDY: A SINGLE ARM STUDY WITH RESOLUTE ONYX IN ONE-MONTH DAPT FOR HIGH-BLEEDING RISK PATIENTS WHO ARE CONSIDERED ONE-MONTH CLEAR (P&S Industry Clinical Trial)
Nov 29 2018 - Nov 29 2023
OPTICAL COHERENCE TOMOGRAPHY (OCT) GUIDED CORONARY STENT IMPLANTATION COMPARED TO ANGIOGRAPHY: A MULTICENTER RANDOMIZED TRIAL IN PCI (P&S Industry Clinical Trial)
Oct 4 2018 - Oct 4 2023
A CLINICAL STUDY TO EVALUATE THE SAFETY AND ACCURACY OF THE SARANAS EARLY BIRD? BLEED MONITORING SYSTEM FOR THE DETECTION OF ENDOVASCULAR PROCEDURE RELATED BLEEDING EVENTS (P&S Industry Clinical Trial)
Sep 5 2018 - Sep 5 2023
MITRAL VALVE REPAIR CLINICAL TRIAL (MAVERIC TRIAL). (P&S Industry Clinical Trial)
Jul 24 2018 - Jul 24 2023
EVALUATION OF TREATMENT STRATEGIES FOR SEVERE CALCIFIC CORONARY ARTERIES: ORBITAL ATHERECTOMY VS. CONVENTIONAL ANGIOPLASTY TECHNIQUE PRIOR TO IMPLANTATION OF DRUG-ELUTING STENTS:(ECLIPSE) (P&S Industry Clinical Trial)
Jul 6 2017 - Jul 6 2022
CEREBRAL PROTECTION OF ACUTE EMBOLIC BURDEN DURING TRANSCATHETER AORTIC VALVE IMPLANTATION IN LOW RISK PATIENTS (Private)
Dec 20 2019 - Dec 21 2020
SAPIEN 3 ULTRA POST MARKET REGISTRY (P&S Industry Clinical Trial)
Jun 9 2020 - Sep 6 2020
INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)
Jul 1 2019 - Jun 30 2020
CLINICAL IMPLEMENTATION OF CLOPIDOGREL PHARMACOGENETICS: THE TAILOR-PCI TRIAL - CCC - LEAD APPLICATION (Federal Gov)
May 16 2016 - Mar 31 2020
REWARDS-PREMIERTLX (REGISTRY EXPERIENCE AT THE WASHINGTON HOSPITAL CENTER, DES PREMIER TAXUS-LIBERTE VS XIENCE V) (P&S Industry Clinical Trial)
Dec 3 2014 - Dec 3 2019
CHAMPIONING CARE FOR THE PATIENT WITH AORTIC STENOSIS (Private)
Dec 16 2013 - Dec 15 2016
LONG-TERM OUTCOMES IN PATIENTS WHO UNDERWENT REVASCULARIZATION IN FREEDOM TRIAL - FOLLOW UP (Private)
May 18 2015 - Dec 31 2015
Selected Publications
Zinc solubility and fractionation in cultivated calcareous soils irrigated with wastewater.
Nazif W1, Marzouk ER2, Perveen S3, Crout NM1, Young SD4
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry
Nazif, et. al.
Starting small but aiming high: important lessons in establishing a successful TAVR program
Nazif TM1, Leon MB2.
For a complete list of publications, please visit PubMed.gov